XSPRAY — XSpray Pharma AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for XSpray Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	210	326	272	120	166
Net Total Accounts Receivable
Net Total Receivables	5.44	2.67	2.5	2.58	4.17
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	216	331	282	132	218
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	43	42.7	44.6	64.6	108
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	401	605	623	585	765
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.5	19.8	30	28.9	39.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	27	22.7	31.2	29.4	71.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	374	583	592	556	693
Total Liabilities & Shareholders' Equity	401	605	623	585	765
Total Common Shares Outstanding